Rigrodsky & Long, P.A. Investigates Caraco Pharmaceutical Laboratories, Ltd. Buyout Proposal
07 December 2010 - 2:15AM
Business Wire
Rigrodsky & Long, P.A. announces that it is investigating
potential claims against the board of directors of Caraco
Pharmaceutical Laboratories, Ltd. (“Caraco” or the “Company”) (NYSE
Amex: CPD) concerning the Company’s receipt of a proposal from Sun
Pharmaceutical Industries Ltd. (“Sun”) and Sun Pharma Global, Inc.
(“Sun Global”) to acquire the remainder of the Company Sun and Sun
Global do not already own in a transaction valued at approximately
$188 million (the “Proposal”). Click here to learn how to join the
action:
http://www.rigrodskylong.com/news/CaracoPharmaceuticalLabs-CPD.
The investigation concerns whether Caraco’s board of directors
is adequately shopping the Company and working to obtain the best
price possible for Caraco’s shareholders. The Proposal contemplates
the acquisition of all of the outstanding shares of common stock of
Caraco not currently owned by Sun and Sun Global for $4.75 per
share in cash. Sun and Sun Global already own approximately 75.8%
of the Company’s outstanding shares.
If you own the common stock of Caraco and purchased your shares
before December 3, 2010, if you have information or would like to
learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development
Director, of Rigrodsky & Long, P.A., 919 N. Market Street,
Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or
by e-mail to info@rigrodskylong.com.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly litigates securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, including claims for breach of
fiduciary duty and proxy violations in the Delaware Court of
Chancery and in state and federal courts throughout the United
States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Caraco (AMEX:CPD)
Historical Stock Chart
From Jan 2025 to Feb 2025
Caraco (AMEX:CPD)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about Caraco Pharmaceutical Laboratories, Ltd. Common Stock (American Stock Exchange): 0 recent articles
More Rigrodsky & Long, P.A. News Articles